Navigation Links
Olive-pomace Oil Compound Inhibits HIV Spread

A new study has found that a compound from olive-pomace oil slows down the spread of HIV virus .

Researchers from the University of Granada and Hospital Carlos III in Madrid, established that maslinic acid, found in wax from olive skin, inhibits serin-protease, the enzyme used by HIV to discharge itself from the infected cell into the extra cellular environment and, subsequently, to spread the infection into the whole body.

These scientists, headed by Prof. Andres Garcia-Granados, senior lecturer in Organic Chemistry are firm that the use of olive-pomace oil can produce an 80% slowing down in AIDS spreading in the body.

Maslinic or crataegolic acid is a pentacyclic terpene with antioxidant and anticancer effects found in wax from olive skin, together with oleanolic acid. The effects of this compound in the battle against AIDS are concurrently being studied in the UGR and in Hospital Carlos III in Madrid by a team headed by Prof. Vallejo Najera.

Maslinic acid's novel properties shoot from its powerful protease-inhibition activity, allowing researchers from Granada to register two patents on behalf of the UGR to produce drugs for treatment of diseases caused by protozoa Cryptosporidium - a parasite causing small intestine infection and diarrhoea - and by HIV. The University of Granada has already registered almost ten other patents related to this compound's properties.

Maslinic acid is also a very active compound in opportunistic parasitic infections seriously affecting HIV patients.

Prof. Andres Garcia-Granados' team intends to continue working in the design and implementation of new maslinic acid by-products to fight against HIV, as well as in other innovative research projects.


'"/>




Page: 1

Related medicine news :

1. Compound of Broccoli combats breast cancer
2. New Compound Could Strengthen The Effect Of Chemotherapy
3. Breathing Cancer Causing Compounds During Pregnancy Found To Affect Offspring
4. Compound from cottonseed for neck and head cancers
5. Compounds Found In The Vegetable Broccoli Could Have Anti-Cancer Properties
6. Adding Sorghum Compounds To Dietary Supplements May Help Lower Cholesterol
7. Compound In Grapes And Red Wine To Counter Alzheimers Disease
8. Sugars Could Contain Key Cancer Inhibiting Compounds
9. Compound From Cyanobacterium Can Fight Alzheimer’
10. Five New Anti-Inflammatory Compounds Produced By Indian Scientists
11. Compounds in Licorice Can Fight Tooth Decay
Post Your Comments:
(Date:12/17/2009)... Is Taking Their Leading Master of Science in Human Resource ... ... Fla. (PRWEB) December 17, 2009 -- Open enrollment has begun ... which is ideal for working professionals whose busy schedules can’t ... in Human Resource Development debuting online in March 2010, location ...
(Date:12/17/2009)... -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) today ... transaction to sell an aggregate of 4,784,689 primary shares ... a price of $2.09 per share, raising aggregate gross ... the financing to close on or about December 22, ... A shelf registration statement relating to the shares of ...
(Date:12/17/2009)... Mechanism to Pursue Approval in Multiple Jurisdictions ... - Labopharm Inc. (TSX: DDS; NASDAQ: ... the regulatory approval process for its twice-daily ... Procedure (DCP). The DCP provides an efficient ... pursue regulatory approval for a medicinal product ...
(Date:12/17/2009)... Calif., Dec. 17 Abaxis, Inc. (Nasdaq: ... point-of-care blood analysis instruments and rapid tests for ... that it has entered the production animal diagnostics ... Influenza Antigen Test. This is a USDA-licensed test ... chickens, turkeys and ducks. The disposable, non-instrumented device, ...
(Date:12/17/2009)... Valerie VanBooven RN BSN author and elder care expert announces the ... Success, Courage and Strength.” Valerie is a contributing author and ... books to be written all year. Now released in paperback, ... office locally. , ... St. Louis, MO (PRWEB) December ...
Breaking Medicine News(10 mins):Health News:A World-Class HR Master's Degree Is Now Within Reach – 100% Online 2Health News:A World-Class HR Master's Degree Is Now Within Reach – 100% Online 3Health News:Neurocrine Announces Sale of 4,784,689 Shares of Common Stock, to Raise Proceeds of $10 Million 2Health News:Neurocrine Announces Sale of 4,784,689 Shares of Common Stock, to Raise Proceeds of $10 Million 3Health News:Labopharm Initiates Regulatory Approval Process for Twice-Daily Tramadol-Acetaminophen in Europe 2Health News:Labopharm Initiates Regulatory Approval Process for Twice-Daily Tramadol-Acetaminophen in Europe 3Health News:ABAXIS(R) Announces Exclusive Worldwide OEM Agreement for a Lateral Flow Avian Influenza Antigen Test Kit 2Health News:ABAXIS(R) Announces Exclusive Worldwide OEM Agreement for a Lateral Flow Avian Influenza Antigen Test Kit 3Health News:ABAXIS(R) Announces Exclusive Worldwide OEM Agreement for a Lateral Flow Avian Influenza Antigen Test Kit 4Health News:Valerie VanBooven RN BSN Announces the Release of her 3rd Book Celebrating Caregivers and Families 2Health News:Valerie VanBooven RN BSN Announces the Release of her 3rd Book Celebrating Caregivers and Families 3
... children who lived close to main roads had a significant ... by 'The Lancet' medical journal.// ,The U.S. researchers ... 10-18, growing up near the roadways (within 500 metres of ... exhaust fumes. Traffic pollution prevents the lungs from developing properly, ...
... of compulsory licenses for inexpensive versions of heart disease ... well with pharmaceutical bigwigs. Health Minister, Mongkol Songkhla, confirmed ... ,According to the Health Minister, the drugs ... did not elaborate on whether the drugs would be ...
... A University of Rochester research review emphasizes that SAD ... should be treated as such. Their review article ... ,Lead author Stephen Lurie, M.D., Ph.D., an assistant ... Medical Center, also noted that SAD is sometimes missed ...
... Scientists at UC Irvine have discovered that learning appears to ... hallmarks of Alzheimer's disease.// The finding suggests that the elderly, ... of this degenerative disease. The study appears in the Jan. ... ,This study with genetically modified mice is the first to ...
... is breast cancer or ovarian cancer, which is feared the most. ... actually die of lung// cancer, as revealed in a new report ... ,Even though men were prone to lung cancer in ... targets due to increase in women smokers. In 2000, lung cancer ...
... of the mineral selenium appear to reduce or slow ... selenium have been noted in HIV-positive patients, and evidence ... system function, the researchers report in the Jan. 22 ... ,"Those individuals who were treated with selenium displayed ...
Other Medicine News:Health News:Study Reviews Seasonal Affective Disorder 2Health News:Learning Slows Physical Progression of Alzheimer's Disease: Study 2Health News:Selenium Supplements May Slow Progression of HIV: Report 2Health News:Selenium Supplements May Slow Progression of HIV: Report 3
(Date:12/17/2009)... Express Scripts, Inc. (Nasdaq: ESRX ), ... companies in North America, announced today results ... of seizure risk among epilepsy patients after ... study found no evidence that switching between ... substitution, was associated with increased emergency room ...
(Date:12/17/2009)... -- Protalix BioTherapeutics, Inc. (NYSE-Amex: PLX ) ... Vice President, Sales and Commercial Affairs. In ... will be responsible for all commercial activities, including ... accordance with the collaboration agreement between the Company ... products that emerge from the Company,s pipeline. ...
(Date:12/16/2009)... Dec. 17 Cell Therapeutics, Inc. ... that on February 10, 2010 the U.S. ... Committee (ODAC) will review the New Drug ... of relapsed/refractory aggressive non-Hodgkin,s lymphoma (NHL). ODAC ... evaluates data concerning the efficacy and safety ...
Breaking Medicine Technology:Express Scripts Study Finds No Association Between Anti-Epileptic Drug Switches and Increased Seizure Activity 2Express Scripts Study Finds No Association Between Anti-Epileptic Drug Switches and Increased Seizure Activity 3Protalix Names Sandra Lauterbach Vice President of Sales and Commercial Affairs 2Protalix Names Sandra Lauterbach Vice President of Sales and Commercial Affairs 3Protalix Names Sandra Lauterbach Vice President of Sales and Commercial Affairs 4Cell Therapeutics Announces FDA's Oncologic Drugs Advisory Committee to Review Pixantrone for the Treatment of Relapsed/Refractory Aggressive Non-Hodgkin's Lymphoma, February 10, 2010 2Cell Therapeutics Announces FDA's Oncologic Drugs Advisory Committee to Review Pixantrone for the Treatment of Relapsed/Refractory Aggressive Non-Hodgkin's Lymphoma, February 10, 2010 3Cell Therapeutics Announces FDA's Oncologic Drugs Advisory Committee to Review Pixantrone for the Treatment of Relapsed/Refractory Aggressive Non-Hodgkin's Lymphoma, February 10, 2010 4Nielsen Announces Finalists for the First Ever CLIO Healthcare Awards 59925 1Nielsen Announces Finalists for the First Ever CLIO Healthcare Awards 59925 2Nielsen Announces Finalists for the First Ever CLIO Healthcare Awards 59925 3Nielsen Announces Finalists for the First Ever CLIO Healthcare Awards 59925 4Nielsen Announces Finalists for the First Ever CLIO Healthcare Awards 59925 5Nielsen Announces Finalists for the First Ever CLIO Healthcare Awards 59925 6Nielsen Announces Finalists for the First Ever CLIO Healthcare Awards 59925 7Nielsen Announces Finalists for the First Ever CLIO Healthcare Awards 59925 8LearntobeHealthy org Adds Mental Health Curriculum for Teens 59923 1LearntobeHealthy org Adds Mental Health Curriculum for Teens 59923 2ERT to Announce 2009 Third Quarter Results on October 29 2009 14568 1ERT to Announce 2009 Third Quarter Results on October 29 2009 14568 2
... , - Novel Treatment Also Demonstrated ... in Depressive Symptoms, Positive data from ... the 8th,European Congress of Epileptology, Berlin, Germany, ... once daily,anti-epileptic agent, significantly reduced the frequency ...
... shows high prevalence of "bothersome" vaginal atrophy, symptoms among ... today at 19th Annual North American Menopause ... ... results of a,Phase 3 study for Ophena(TM) (ospemifene tablets) for the ...
Other Medicine Technology:New Data Show Efficacy of Zebinix(TM) in the Treatment of Epilepsy 2New Data Show Efficacy of Zebinix(TM) in the Treatment of Epilepsy 3New Data Show Efficacy of Zebinix(TM) in the Treatment of Epilepsy 4New Data Show Efficacy of Zebinix(TM) in the Treatment of Epilepsy 5New Data Show Efficacy of Zebinix(TM) in the Treatment of Epilepsy 6QuatRx Pharmaceuticals Announces Additional Data From Phase 3 Study for Ophena(TM) (Ospemifene Tablets) Showing Improvements in Clinical Symptoms of Vulvovaginal Atrophy 2QuatRx Pharmaceuticals Announces Additional Data From Phase 3 Study for Ophena(TM) (Ospemifene Tablets) Showing Improvements in Clinical Symptoms of Vulvovaginal Atrophy 3QuatRx Pharmaceuticals Announces Additional Data From Phase 3 Study for Ophena(TM) (Ospemifene Tablets) Showing Improvements in Clinical Symptoms of Vulvovaginal Atrophy 4
... VHD was the first ... bleeding after diagnostic and ... procedures. It is a ... approved for immediate sheath ...
... VasoSeal VHD was ... rapidly stop bleeding after ... and radiology procedures. It ... sealing device approved for ...
... collagen hemostat. FirstStop is a non-friable, non-woven ... characteristics. It can easily be cut to ... FirstStop products are not dispersed when wet ... hemostasis is achieved. As the collagen forms ...
InterVascular HemaCarotid Patch product line offers the vascular surgeon a complete range of knitted, collagen coated patches in a wide range of sizes for carotid endarterectomy and angioplasty witho...
Medicine Products: